Search clinical trials for: Olaparib Oral Tablet [Lynparza]
Total 2095 results
-
Fulcrum TherapeuticsCompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, Canada, France, Spain
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedDiabetes Mellitus, Type 2China
-
Fudan UniversityUnknownSoft Tissue Sarcoma Adult | High Grade SarcomaChina
-
PRCL Research Inc.Completed
-
BayerCompleted
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
Charles A. Czeisler, PhD, MDAxsome Therapeutics, Inc.RecruitingExcessive Sleepiness | Shift-work DisorderUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; Johns Hopkins University and other collaboratorsCompletedCannabis Use DisorderUnited States
-
Stony Brook UniversityEisai Inc.TerminatedAmyotrophic Lateral SclerosisUnited States
-
Helsinn Healthcare SACompletedNon Small Cell Lung Cancer | Cachexia; CancerUnited States, Russian Federation, Bulgaria, Hungary, Italy, Romania, Serbia
-
Helsinn Healthcare SACompletedNon Small Cell Lung Cancer | Cachexia; CancerUnited States, Croatia, Australia, Belgium, Russian Federation, Poland, Romania, Ukraine
-
SensorionCompletedSevere Sudden Sensorineural Hearing LossIsrael, United Kingdom, France, Serbia, Bulgaria, Canada, Czechia, Germany, Slovakia, Turkey
-
Dana-Farber Cancer InstituteAmgenTerminatedLymphoma | Autonomic Imbalance | Cancer SurvivorshipUnited States
-
Jazz PharmaceuticalsCompletedNarcolepsyUnited States, France, Canada, Germany, Finland, Netherlands
-
Jazz PharmaceuticalsCompletedObstructive Sleep ApneaUnited States, France, Canada, Germany, Netherlands
-
University Hospital, GrenobleUnknown
-
Mission PharmacalUnknown
-
PfizerMedivation, Inc.Terminated
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
AstraZenecaCompletedSolid TumoursFrance, United Kingdom, Czechia, Korea, Republic of, Netherlands
-
Industrial Farmacéutica Cantabria, S.A.Bioskin GmbH; BioClever 2005 S.L.Not yet recruitingAndrogenetic Alopecia | Female Pattern Baldness
-
Affiliated Cancer Hospital & Institute of Guangzhou...UnknownHepatitis B | Non Small Cell Lung CancerChina
-
National Cancer Institute (NCI)RecruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian CarcinomaUnited States
-
Grupo Espanol Multidisciplinario del Cancer DigestivoMerk Sharp & Dohme España S.A.RecruitingMetastatic Colorectal CancerSpain
-
University Health Network, TorontoRecruitingGlioma | Solid Tumor | Cholangiocarcinoma | IDH MutationCanada
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom, Italy
-
Saitama Medical University International Medical...National Cancer Center, Japan; Tokyo University; Cancer Institute Hospital, Japan and other collaboratorsActive, not recruiting
-
Seoul National University HospitalAstraZenecaActive, not recruitingBreast NeoplasmsKorea, Republic of
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Handok Inc.Recruiting
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer CenterRecruitingMetastatic MelanomaUnited States
-
Georgetown UniversityActive, not recruiting
-
Handok Inc.Recruiting
-
Amygdala Neurosciences, Inc.CompletedHealthy VolunteersUnited States
-
University of Erlangen-Nürnberg Medical SchoolBayerRecruiting
-
University of Alabama at BirminghamEli Lilly and CompanyNot yet recruitingFrontal Fibrosing AlopeciaUnited States
-
Istituto Oncologico Veneto IRCCSCompletedGlioblastoma MultiformeItaly
-
Rochester Center for Behavioral MedicineActive, not recruitingChronic Fatigue Syndrome | Myalgic EncephalomyelitisUnited States
-
Oscotec Inc.CompletedImmune ThrombocytopeniaUnited States, Greece, Korea, Republic of, Poland, Spain
-
Aminex Therapeutics, Inc.Iqvia Pty Ltd; Novella ClinicalWithdrawnNeoplasms | Tolerance | Medication ToxicityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedDisease or R Group HistiocytosesFrance
-
Deciphera Pharmaceuticals LLCCompletedGastrointestinal Stromal TumorsUnited States, France, Finland, United Kingdom, Germany, Netherlands, Italy, Belgium, Spain, Canada, Australia, Poland, Singapore
-
Galapagos NVTerminated
-
ShionogiQuatRx PharmaceuticalsCompleted
-
PfizerCompleted
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
Chang Gung Memorial HospitalRecruitingThyroid Disease PregnancyTaiwan